Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Engert

Showing results (21-30 of 379) with videos related to

Pageof 38
Sort By:
Seminars in Hematology|August 7, 2016
Hodgkin lymphoma: IntroductionAndreas Engert, Theodoros P Vassilakopoulos
Current Hematologic Malignancy Reports|May 30, 2015
The GHSG Approach to Treating Hodgkin's LymphomaPaul J Bröckelmann, Andreas Engert
Expert Review of Hematology|July 1, 2017
The evolving role of targeted drugs in the treatment of Hodgkin lymphomaDennis A Eichenauer, Andreas Engert
Current Opinion in Oncology|August 15, 2013
Refractory Hodgkin lymphomaBastian von Tresckow, Andreas Engert
Current Hematologic Malignancy Reports|May 14, 2011
The role of autologous transplantation in Hodgkin lymphomaBastian von Tresckow, Andreas Engert
Leukemia & Lymphoma|November 4, 2009
Is there a role for BEACOPP (bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, prednisone) in relapsed Hodgkin lymphoma?Dennis A Eichenauer, Andreas Engert
Blood|July 29, 2017
R-CHOP in NLPHL: who should receive it?Dennis A Eichenauer, Andreas Engert
Blood|September 3, 2020
How I treat nodular lymphocyte-predominant Hodgkin lymphomaDennis A Eichenauer, Andreas Engert
Expert Review of Hematology|November 14, 2012
The emerging role of PET in Hodgkin lymphoma patients receiving autologous stem cell transplantBastian von Tresckow, Andreas Engert
Hematological Oncology|June 19, 2013
VII. Management of nodular lymphocyte-predominant Hodgkin lymphomaDennis A Eichenauer, Andreas Engert
Pageof 38

Showing results (21-30 of 379) with videos related to

Sort By:
Pageof 38
Seminars in Hematology|August 7, 2016
Hodgkin lymphoma: IntroductionAndreas Engert, Theodoros P Vassilakopoulos
Current Hematologic Malignancy Reports|May 30, 2015
The GHSG Approach to Treating Hodgkin's LymphomaPaul J Bröckelmann, Andreas Engert
Expert Review of Hematology|July 1, 2017
The evolving role of targeted drugs in the treatment of Hodgkin lymphomaDennis A Eichenauer, Andreas Engert
Current Opinion in Oncology|August 15, 2013
Refractory Hodgkin lymphomaBastian von Tresckow, Andreas Engert
Current Hematologic Malignancy Reports|May 14, 2011
The role of autologous transplantation in Hodgkin lymphomaBastian von Tresckow, Andreas Engert
Leukemia & Lymphoma|November 4, 2009
Is there a role for BEACOPP (bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, prednisone) in relapsed Hodgkin lymphoma?Dennis A Eichenauer, Andreas Engert
Blood|July 29, 2017
R-CHOP in NLPHL: who should receive it?Dennis A Eichenauer, Andreas Engert
Blood|September 3, 2020
How I treat nodular lymphocyte-predominant Hodgkin lymphomaDennis A Eichenauer, Andreas Engert
Expert Review of Hematology|November 14, 2012
The emerging role of PET in Hodgkin lymphoma patients receiving autologous stem cell transplantBastian von Tresckow, Andreas Engert
Hematological Oncology|June 19, 2013
VII. Management of nodular lymphocyte-predominant Hodgkin lymphomaDennis A Eichenauer, Andreas Engert
Pageof 38